Breaking News

Abortion providers embrace tech to prepare for flood of patients; what investors make of a decline in health tech funding

 

Daily Recap

Abortion providers embrace virtual assistants and automation to prepare for new flood of patients

By Mohana Ravindranath

Tami Chappell for STAT

Providers in states where abortion is still legal are expecting an influx of patients. They're hoping technology can help them manage.

Read More

STAT+: Health tech funding is down. Here's what investors make of the market

By Mario Aguilar

Adobe

Health tech funding is down, deal sizes are smaller, and M&A has slowed. Investors told STAT what they make of the market right now.

Read More

Inaccurate pulse oximeter readings tied to less supplemental oxygen for darker-skinned ICU patients

By Usha Lee McFarling

Photo by Mario Tama/Getty Images

ICU patients with darker skin who received less accurate pulse oximeter readings also received less supplemental oxygen, a new study found.

Read More

Drugmaker seeks FDA approval of over-the-counter birth control pill

By Associated Press

Sarah Silbiger/Getty Images

HRA Pharma's application sets up a high-stakes decision for health regulators amid battles over women's reproductive health.

Read More

Opinion: Secrecy: A demon of gene therapy's past bedevils its future

By Eric B. Kmiec

Adobe

The field of gene therapy was once severely damaged by not openly sharing essential information. It may be making the same mistake again.

Read More

Opinion: Dobbs decision will rob many medical students of essential abortion training

By Kellen Mermin-Bunnell and Ariana M. Traub

Rogelio V. Solis/AP

The Supreme Court's decision to remove federal protection for abortion care undermines medical education and future physicians' competence.

Read More

Monday, July 11, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments